Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) With Pilocarpine Eye Drops in Subjects With Presbyopia

Next Previous
Trial Profile

Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) With Pilocarpine Eye Drops in Subjects With Presbyopia

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 31 Oct 2023

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Most Recent Events

  • 26 Oct 2023 According to an Ocuphire Pharma media release, data from this study will be presented at the American Academy of Ophthalmology Annual Meeting (AAO 2023) to take place in San Francisco, California on November 3-6, 2023.
  • 07 Sep 2023 According to an Ocuphire Pharma media release, data from this study will be presented at the 2023 European Society of Cataract and Refractive Surgeons (ESCRS).
  • 02 May 2023 According to an Ocuphire Pharma media release, results from this trial will be presented at the American Society of Cataract and refractive Surgery (ASCRS) 2023 and will be featured in the Marketplace Company Showcase at Eyecelerator ASCRS 2023 on May 4.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top